Cannabis Blog

(image via McGill.ca)

This is a notice of a conference of significance in the medical cannabis field. The Research Summit will be held on March 22-23 at the Natcher Conference Center on the National Institutes of Health campus in Bethesda, Maryland.

After viewing the advertisement for the event I question the premise, as the cannabinoid system itself has no adverse effects; the phrasing of the event’s summary implies a bias toward finding harm, a charge that Dr. Sanjay Gupta and other have levied against the NIH and NIDA for some time.

The discussions will include a Michigan contingent, as Dr. Christine Rabinak from Wayne State University will participate in the section reserved for Therapeutic Potential: Epilepsy, Multiple Sclerosis, Pain, PTSD/Anxiety. 

She was the lead author on a paper published in 2013 regarding marijuana use and PTSD.

www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/

Read More:http://www.theweedblog.com/marijuana-and-cannabinoids-a-neuroscience-research-summit/